Ibrance 100 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F1QAG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,560
Award facts
- Contract value 100% obligated
- $8,559.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to Amerisourcebergen Drug Corp for the supply of Ibrance 100 mg capsules (21 count) with a completion date of February 4, 2026. This competitive award, issued on January 13, 2026, involves firm fixed-price pricing with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office and primary distribution operations.
This delivery order is executed under Amerisourcebergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains. Ibrance, a brand-name oncology medication, represents the type of specialized pharmaceutical product routinely procured through this contract mechanism to support the Defense Health Agency and other federal medical systems.
Quick answers
Who was awarded contract SPE2DR26F1QAG?
SPE2DR26F1QAG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F1QAG worth?
The government has obligated $8,560 on SPE2DR26F1QAG.
Is contract SPE2DR26F1QAG an order under another contract?
Yes. SPE2DR26F1QAG is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1QAG competed?
The extent of competition for SPE2DR26F1QAG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award